Jt. Wachsman, THE BENEFICIAL-EFFECTS OF DIETARY RESTRICTION - REDUCED OXIDATIVE DAMAGE AND ENHANCED APOPTOSIS, Mutation research, 350(1), 1996, pp. 25-34
There is compelling evidence for the central role of oxidative damage
in the aging process and for the participation of reactive oxygen spec
ies in tumor initiation and promotion. Caloric restriction (CR) or ene
rgy restriction retards age-associated increases in mitochondrial free
-radical production and reduces the accumulation of oxidatively damage
d cell components. CR has also been shown to slow down age-related dec
lines in various repair capabilities, including some types of DNA repa
ir. It is proposed that inhibitors of mitochondrial electron transport
and/or uncouplers of oxidative phosphorylation (rotenone, amytal, ami
odarone, valinomycin, etc.), when used at extremely low doses, could m
imic the effects of CR in model systems. The objective is to lower mit
ochondrial free-radical production by decreasing the fraction of elect
ron carriers in the reduced state. In addition to a variety of other e
ffects, CR has been shown to increase the rate of apoptosis, particula
rly in preneoplastic cells, and in general, to promote elevated levels
of free glucocorticoids (GCs). GCs are known to induce tissue-specifi
c apoptosis and to upregulate gap-junction-mediated intercellular comm
unication (GJIC). Tumor promoters like phorbol eaters have the opposit
e effect, in that they inhibit both the process of apoptosis and GJIC.
The enzyme poly (ADP-ribose) polymerase (PARP) is thought to play a c
entral role in apoptosis, in a manner that has been highly conserved i
n evolution. There is good evidence that the apoptosis-associated Ca/M
g-dependent DNA endonuclease is maintained in a latent form by being p
oly (ADP-ribosylated). Apoptosis would require the removal of this pol
ymer from the endonuclease, and, most likely, its removal from topoiso
merase II and histone H1 as well. The role of poly (ADP-ribose) in apo
ptosis, carcinogenesis, and aging could be studied by the use of modul
ators of PARP activity (3-aminobenzamide, 3-nitrosobenzamide, 1% ethan
ol, etc.), inhibitors of poly (ADP-ribose) glycohydrolase activity (et
hacridine, 43 degrees C, etc.), and inhibitors of the PARP-specific pr
otease (interleuken-1 beta converting enzyme (ICE)-like protease). Als
o, it would be of interest to determine if CR can decrease the half-li
fe of poly (ADP-ribose), upregulate GJIC, and modulate the activities
of PARP, the glycohydrolase, and the PARP-specific protease, factors p
otentially important in these processes.